A doctor reflects on how raising a son with Angelman syndrome reshaped his family, deepened his empathy and turned grief into ...
For the first time, the Brazilian Football Confederation (CBF) joins Angelman Brasil in a national awareness campaign about Angelman Syndrome, a rare and still little-known genetic condition. The ...
ORLANDO, Fla.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, announced today that ...
KANSAS CITY, Mo. (KCTV) - Four-year-old Maddie loves cheese and fruit snack gummies, being right in the middle of the action, and playing with her twin sister, Kellie, and older brother, Colin. When ...
Colin Farrell is elaborating on a big parenting decision he made. The “Penguin” star, 48, revealed in a new interview with Candis magazine that he and his ex, model Kim Bordenave, put their ...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. The initial participant in the pivotal Phase 3 REVEAL trial, which is assessing ION582 ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ION582 ...
Ionis Pharmaceuticals, which is developing a treatment for the rare neurological disease of Angelman syndrome (AS), turned to Lifetime Television’s “Behind the Mystery” series to increase public ...
Colin Farrell has made the hard decision to put his 21-year-old son James, who suffers from Angelman syndrome, in a long-term care facility. “It’s tricky – some parents will say, ‘I want to take care ...